Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis : a therapeutic study using a macrophage-deactivating compound

Am J Pathol. 2001 Feb;158(2):491-500. doi: 10.1016/S0002-9440(10)63991-0.

Abstract

This study was performed to elucidate pathophysiological events before and during the course of collagen-induced arthritis in Dark Agouti rats, a model for rheumatoid arthritis. Kinetic studies of local cytokine responses were determined using immunohistochemical techniques, quantified by computer-assisted image analysis. We recently reported that the macrophage-pacifying agent CNI-1493 successfully ameliorated collagen-induced arthritis. In the present trial, we investigated the potential of CNI-1493 to down-regulate pro-inflammatory cytokines. Synovial cryosections were analyzed at various time points for the presence of interleukin (IL)-1beta, tumor necrosis factor (TNF), and transforming growth factor (TGF)-beta. Unexpectedly, an early simultaneous TNF and IL-1beta expression was detected in resident cells in the lining layer, preceding disease onset and inflammatory cell infiltration by >1 week. The predominant cytokine synthesis by synovial (ED1+) macrophages coincided with clinical disease. TNF production greatly exceeded that of IL-1beta. CNI-1493 treatment did not affect the early disease-preceding TNF and IL-1beta synthesis in the lining layer. However, after disease onset, CNI-1493 intervention resulted in a pronounced reduced IL-1beta and in particular TNF expression. Furthermore, CNI-1493 significantly up-regulated synthesis of the anti-inflammatory cytokine TGF-beta and thereby shifted the balance of pro-inflammatory and anti-inflammatory cytokines in the arthritic joint in a beneficial way.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis / chemically induced
  • Arthritis / metabolism*
  • Arthritis / prevention & control
  • Collagen / administration & dosage*
  • Cytokines / antagonists & inhibitors
  • Cytokines / biosynthesis*
  • Cytokines / drug effects
  • Hydrazones / therapeutic use
  • Immunohistochemistry
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / biosynthesis
  • Male
  • Rats
  • Rats, Inbred Strains
  • Synovial Membrane / chemistry*
  • Synovial Membrane / cytology
  • Synovial Membrane / drug effects
  • Time Factors
  • Transforming Growth Factor beta / biosynthesis
  • Transforming Growth Factor beta / drug effects
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • Hydrazones
  • Interleukin-1
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha
  • Collagen
  • semapimod